Umoja Biopharma to Present at Evercore ISI HealthCONx Conference
26 Nov 2024 //
GLOBENEWSWIRE
Umoja Biopharma Appoints Scott as Chairman of Board of Directors
21 Nov 2024 //
GLOBENEWSWIRE
Umoja Biopharma Announces Presentations at ASH Annual Meeting
05 Nov 2024 //
GLOBENEWSWIRE
Umoja Biopharma Announces Posters At SITC Annual Meeting
04 Oct 2024 //
GLOBENEWSWIRE
Umoja Biopharma to Present At American College Of Rheumatology
30 Sep 2024 //
GLOBENEWSWIRE
Nona Biosciences And Umoja Partner On In Vivo CAR-T Therapies
12 Sep 2024 //
PR NEWSWIRE
Umoja Biopharma to Present at the 9th Annual CAR-TCR Summit
11 Sep 2024 //
GLOBENEWSWIRE
Umoja Biopharma to Participate in Upcoming Investor Conferences in September
29 Aug 2024 //
GLOBENEWSWIRE
Umoja Biopharma`s UB-VV111 IND Cleared By FDA
31 Jul 2024 //
GLOBENEWSWIRE
Umoja Announces Publication of In Vivo CAR T-cells in Non-Human Primate Modeling
13 Jun 2024 //
GLOBENEWSWIRE
Umoja Biopharma to Present at H.C. Wainwright Virtual Conference
19 Mar 2024 //
GLOBENEWSWIRE
Umoja Bio Announces Appointment of Britton Russell as Chief Financial Officer
28 Feb 2024 //
GLOBENEWSWIRE
Umoja Bio to Participate in a Fireside Chat at the Evercore ISI 2024 Conference
22 Feb 2024 //
GLOBENEWSWIRE
AbbVie extends oncology reach via in-situ CAR-T pact worth $1.4B
05 Jan 2024 //
PR NEWSWIRE
AbbVie taps Umoja for new in vivo CAR-T deal
04 Jan 2024 //
ENDPTS
IASO BIO Announces New Development Partnership with Umoja Biopharma
03 Jan 2024 //
PR NEWSWIRE
Umoja Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
GLOBENEWSWIRE
Umoja Biopharma Presents Data at the 65th Hematology Annual Meeting
11 Dec 2023 //
GLOBENEWSWIRE
Umoja Biopharma Announces Oral Presentation at Hematology Annual Meeting
02 Nov 2023 //
GLOBENEWSWIRE
Umoja Biopharma Announces Opening of Manufacturing Facility in Colorado
19 Oct 2023 //
GLOBENEWSWIRE
Umoja Biopharma to Present at the 2023 Cell & Gene Meeting on the Mesa
05 Oct 2023 //
GLOBENEWSWIRE
Umoja VivoVec Platform Presents Encouraging Data in Study at 8th CAR-TCR Summit
01 Sep 2023 //
GLOBENEWSWIRE
Umoja Biopharma to Unveil Positive Data for the First Time at 8th CAR-TCR Summit
23 Aug 2023 //
GLOBENEWSWIRE
Umoja Biopharma to Present at the 2023 BIO International Convention
31 May 2023 //
GLOBENEWSWIRE
Umoja wants to move CAR T beyond the `Goldilocks patients`
23 May 2023 //
FIERCE BIOTECH
Umoja Biopharma Presents New Preclinical Data at the American Society
17 May 2023 //
GLOBENEWSWIRE
Umoja to Present New Data at the American Society of Gene and Cell Therapy
03 May 2023 //
GLOBENEWSWIRE
Umoja Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 //
GLOBENEWSWIRE
Umoja Biopharma Appoints Dieter Weinand as the Chair of its Board of Directors
14 Dec 2022 //
GLOBENEWSWIRE
Umoja and IASO partner to develop therapies for haematological malignancies
22 Nov 2022 //
PHARMACEUTICAL-TECHNOLOGY
Umoja Biopharma and IASO Biotherapeutics Announce Research Collaboration
21 Nov 2022 //
GLOBENEWSWIRE
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR T
10 Nov 2022 //
GLOBENEWSWIRE
Umoja to Present Posters Data on Integrated In Vivo CAR T and ShRED Platform
19 Oct 2022 //
GLOBENEWSWIRE
Umoja Biopharma Presents New Preclinical Data at 2022 iPSC Manufacturing Summit
28 Jul 2022 //
GLOBENEWSWIRE
Umoja Biopharma Announces Participation in Upcoming Scientific Summits
30 Jun 2022 //
GLOBENEWSWIRE
Umoja Presents Data on its Engineered Induced Pluripotent Stem Cell Platform
16 Jun 2022 //
GLOBENEWSWIRE
Umoja Biopharma and TreeFrog Announce Collaboration in Immuno-Oncology
10 Jun 2022 //
GLOBENEWSWIRE
Umoja Biopharma and Lupagen Announce New Collaboration for Cancer
23 May 2022 //
GLOBENEWSWIRE
Umoja Biopharma Announces Resignation of Board Chair Clay B. Siegall
11 May 2022 //
GLOBENEWSWIRE
Umoja Biopharma Presents Data on its Synthetic Cytokine Receptor Platform
04 May 2022 //
GLOBENEWSWIRE
Umoja Activates of First ENLIGHTen PI Trial Site in Study of UB-TT170
03 May 2022 //
GLOBENEWSWIRE
Umoja Biopharma to Present at the ASGCT
02 May 2022 //
GLOBENEWSWIRE
Umoja Biopharma Presents Data on its iPSC-Based Cell Therapy Platform at AACR
08 Apr 2022 //
GLOBENEWSWIRE
Umoja Biopharma Appoints Clay Siegall, as Chairman of the Board
18 Oct 2021 //
PRNEWSWIRE
CRB, Umoja Biopharma Begin Construction at Development and Manufacturing Site
03 Sep 2021 //
CONTRACTPHARMA
CRB, Umoja Biopharma Begin Construction at Development and Manufacturing Site
03 Sep 2021 //
CONTRACT PHARMA
Hot off of a $210M Series B, Umoja breaks ground in Colorado on CAR-T site
02 Sep 2021 //
ENDPTS
Umoja aims immunotherapies at the clinic with $210M raise
15 Jun 2021 //
FIERCEBIOTECH
Umoja Biopharma Closes an Oversubscribed $210 Million Series B Financing
15 Jun 2021 //
PRNEWSWIRE
Umoja Biopharma Announces Appointment of David Fontana
08 Jun 2021 //
PRNEWSWIRE